Follow a representative sample of Latin American patients diagnosed with atrial fibrillation to set data on demographic characteristics, documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death
Patients will be followed 6 months and 1 year after the baseline visit and will be collected data of antithrombotic therapy, laboratory data, discontinuation rates of antithrombotic therapy and clinical outcomes.
To set data on demographic characteristics,documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death.
Bahía Blanca, Buenos Aires, Argentina
Ramos Mejía, Buenos Aires, Argentina
Temperley, Buenos Aires, Argentina
Buenos Aires, La Plata, Argentina
San Miguel de Tucumán, Tucumán Province, Argentina
Córdoba, Argentina
Salta, Argentina
San Juan, Argentina
San Luis, Argentina
Santa Fe, Argentina
Santa Fe, Argentina